🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ StockGenie AI

DocGo Inc. DCGO R2K

Healthcare · Medical Care Facilities · United States
https://docgo.com

DocGo Inc. operates as a mobile healthcare services company in the United States and the United Kingdom. It operates through Mobile Health Services and Transportation Services segments. The company offers transportation services comprising emergency response services; and non-emergency transport services, such as ambulance and wheelchair transportation services. It also provides mobile health services through its care delivery platform that are performed at home, offices, and other locations comprising mobile urgent care, exams, vaccinations, monitoring and care management, procedures, point-of-care tests, and screenings and coaching; event services, including on-site healthcare support at sporting events and concerts; virtual care management; and remote patient monitoring and chronic disease management services. The company serves municipalities, hospitals and health systems, states and communities, insurers, physician practices, health plans, and businesses and employees. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.

READ MORE ›
$0.66
-53.66% 1Y

Market & Price

Market Cap
$65.00M
Current Price
$0.66
High / Low (52W)
$1.73 / $0.52
Beta
1.02

Valuation

Stock P/E
-
Industry PE
23.65
Forward P/E
12.93
PEG Ratio
-
Book Value
$1.34
Price to Book
0.49
P/S
0.22
EV/EBITDA
-0.46
Dividend Yield
-

Profitability & Returns

ROCE
-59.59%
ROE
-97.78%
ROA
-18.33%
Profit Margin
-62.23%
Op Margin
-24.77%
EPS (Latest Qtr)
$-0.15
EPS (TTM)
$-1.90

Balance Sheet & Liquidity

Debt/Equity
0.26
Quick Ratio
1.68
Current Ratio
1.79
Debt
$28.51M
Total Assets
$217.10M
Current Assets
$152.40M
Working Capital
$84.91M

Ownership

Promoter Holding
3.07%
Chg in Prom Hold
-
FII / Inst Holding
43.27%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
$36.73M
Total Revenue (TTM)
$301.71M
EBITDA
$-79.32M
Free Cash Flow
$43.99M
Operating Cash Flow
$20.58M
Shares Outstanding
98.78M
Gross Margin
30.42%
Payout Ratio
0.00%

Growth (CAGR)

Revenue 5Y
-9.90%
Profit 5Y
-209.13%
Revenue (YoY)
-21.30%
Earnings (YoY)
-

PROS

  • Generates positive free cash flow.

CONS

  • Revenue declined at -9.9% CAGR over 5 years.
  • Earnings shrank at -209.1% CAGR over 5 years.
  • Trading 62.0% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP $P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 DCGO DocGo Inc. R2K 0.66 - $65.00M - -59.59% -97.78% -9.90% -209.13%
2 LLY Eli Lilly and Company SPX 1,105.00 39.21 $985.37B 0.63% 38.44% 107.46% 31.69% 48.96%
3 JNJ Johnson & Johnson SPX 225.33 26.11 $542.42B 2.38% 23.13% 26.42% 5.60% 14.32%
4 UNH UnitedHealth Group Incorporated SPX 380.31 28.66 $345.38B 2.32% 9.60% 12.18% 11.35% -15.69%
5 MRK Merck & Co., Inc. SPX 118.72 33.44 $293.22B 2.86% 20.66% 18.94% 3.12% 7.93%
6 TMO Thermo Fisher Scientific Inc. SPX 492.51 27.11 $183.03B 0.38% 9.17% 13.52% -0.27% -1.19%
7 AMGN Amgen Inc. NDXSPX 336.79 23.42 $181.77B 2.99% 18.02% 101.32% 11.77% 5.58%
8 GILD Gilead Sciences, Inc. NDXSPX 134.43 18.29 $166.90B 2.44% 22.92% 43.36% 2.57% 22.83%
9 ISRG Intuitive Surgical, Inc. NDXSPXAI 424.64 51.53 $150.39B - 15.96% 17.23% 17.39% 29.26%
⚙Ad space

Quarterly Results

Figures in USD.

Metric Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue 49.69M62.19M85.84M117.89M109.52M104.32M113.00M125.49M186.55M192.09M164.95M-96.03M80.42M70.81M74.94M75.55M
Cost of Revenue ------------65.19M55.00M52.68M50.57M51.67M
Gross Profit ------------30.85M25.42M18.13M24.36M23.88M
Operating Expenses ------------44.85M42.90M43.36M56.81M42.59M
Operating Income -1.87M258.76K1.52M10.09M7.46M4.20M-6.90M1.58M8.71M15.88M10.15M--14.00M-17.48M-25.24M-32.44M-18.71M
EBITDA -------------10.62M-13.49M-21.27M-28.49M-13.93M
Interest Expense ------------426.28K443.66K--99.73K
Pretax Income -------------14.80M-17.92M-43.17M-111.61M-16.68M
Tax Provision -------------3.72M-4.63M-13.51M30.73M19.28K
Net Income -2.00M102.01K801.57K10.63M11.76M2.47M-3.47M--11.23M6.53M--9.41M-11.16M-27.77M-134.07M-14.76M
Diluted EPS -0.03-18.190.040.090.110.03-0.03-0.020.050.100.06--0.09-0.11-0.28-1.37-0.15
R&D Expense 569.35K664.88K854.62K1.14M1.15M1.37M1.86M2.57M3.24M2.39M2.37M3.15M3.64M2.96M3.19M-3.71M

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue 94.09M-440.52M624.29M616.56M322.20M
Cost of Revenue --285.79M428.91M402.98M223.44M
Gross Profit --154.72M195.38M213.57M98.76M
Operating Expenses --132.89M180.33M184.89M187.91M
Operating Income -14.76M-21.83M15.05M28.69M-89.16M
EBITDA --32.40M31.49M44.57M-73.50M
Interest Expense -763.03K--1.93M-
Pretax Income --22.78M16.29M27.75M-187.50M
Tax Provision ---7.96M6.24M14.39M8.87M
Net Income -14.80M-34.58M6.86M19.99M-182.40M
Diluted EPS -0.250.250.340.060.18-
R&D Expense 1.19M3.32M5.38M10.86M11.59M13.56M

Compounded Sales Growth

5 Years:-9.90%
1 Year:-21.30%

Compounded Profit Growth

5 Years:-209.13%
1 Year:-

Stock Price Performance

1 Year:-53.66%
6 Months:-35.17%
3 Months:-8.36%
1 Month:-6.93%

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets -100.17M-393.28M490.45M455.62M217.10M
Current Assets ---271.08M338.87M304.49M152.40M
Cash & Equivalents -32.42M-157.34M59.29M89.24M51.02M
Inventory -------
Receivables ---103.00M262.08M210.90M92.89M
Total Liabilities -33.23M-114.35M185.28M140.44M91.23M
Current Liabilities -23.50M-100.16M170.12M121.81M67.49M
Long Term Debt ---1.24M41.59K5.21K183.84K
Total Debt ---19.91M46.50M57.19M29.18M
Total Equity 79.36M55.00M-273.23M300.79M320.92M144.01M
Shares Outstanding ---102.41M104.06M101.91M98.64M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow -10.65M-28.87M-64.49M70.12M34.45M
Investing Cash Flow -6.04M--38.45M-29.61M-10.65M-39.08M
Financing Cash Flow -812.09K--6.18M1.12M-24.15M-50.82M
Capital Expenditure -4.36M--5.50M-9.85M-5.61M-7.43M
Free Cash Flow -15.02M-23.37M-74.35M64.50M27.02M
Net Change in Cash ---15.76M-92.98M35.31M-55.45M
Share Buybacks -03.73M013.76M10.83M

Ratios (Annual)

Figures in %.

Metric Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % --35.1%31.3%34.6%30.7%
Operating Margin % -15.7%-5.0%2.4%4.7%-27.7%
Net Margin % -15.7%-7.9%1.1%3.2%-56.6%
ROE % -26.9%-12.7%2.3%6.2%-126.7%
ROCE % -19.2%-7.4%4.7%8.6%-59.6%

Shareholding Pattern

Insiders
3.07%
Institutions
43.27%
Public Float
44.64%

Top Institutional Holders

#Holder% HeldSharesValue
1 Blackrock Inc. 6.44% 6.37M $4.19M
2 Vanguard Capital Management LLC 3.73% 3.68M $2.42M
3 P.A.W. Capital Corp 3.04% 3.00M $1.97M
4 Knott David M., Jr. 2.70% 2.67M $1.76M
5 Citadel Advisors Llc 2.53% 2.50M $1.64M
6 Geode Capital Management, LLC 2.44% 2.41M $1.59M
7 S Squared Technology, LLC 2.08% 2.06M $1.35M
8 State Street Corporation 1.99% 1.97M $1.29M
9 Acadian Asset Management. LLC 1.54% 1.52M $1.00M
10 Renaissance Technologies, LLC 1.53% 1.51M $993.82K

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for DCGO

No recent headlines available.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space